Ibandronate Sodium Tablet, Film Coated
Product Images NDC 60505-2795

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ibandronate Sodium (NDC 60505-2795). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ibandronate-01 (Ibandronate 01)

FDA Label Image

Image-01.jpg (Image 01)

Image-01.jpg (Image 01)
This appears to be instructions for taking a medication called Bandronate Sodium Tablet 150 mg for osteoporosis. The packet contains a monthly supply and should be taken once a month on a chosen day. There are detailed instructions on how to take the pill and reminders to follow the schedule. The pharmacist's guide is mentioned as well as a contact number. However, there are some errors, and the text is difficult to read in places, making it challenging to understand the complete instructions.*
FDA Label Image

Instructions1.jpg (Instructions1)

FDA Label Image

Instructions2.jpg (Instructions2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.